<DOC>
	<DOCNO>NCT01177319</DOCNO>
	<brief_summary>This investigator initiate pilot study examine effect GSH PD . The goal study acquire basic data regard side effect efficacy compound determine possible treatment option could recommend interested PD patient .</brief_summary>
	<brief_title>Glutathione ( GSH ) In The Treatment Parkinson 's Disease</brief_title>
	<detailed_description>Inclusion Criteria Idiopathic Parkinson 's disease ( 2 3 cardinal symptom , tremor , bradykinesia , rigidity ) Mini Mental State Examination &gt; 24 Anti-parkinsonian medication stable one month Hoehn Yahr II-IV Exclusion Criteria Atypical parkinsonism History seizure , drug addiction Use typical neuroleptic Previous use glutathione Methods Study Design The study parallel , double-blind , placebo control trial last one month three glutathione injection per week . Glutathione supply Wellness Health Pharmaceuticals Birmingham , Alabama . Drug Administration The drug placebo ( 1:1 ratio ) administer intravenously dose 1400 mg Monday , Wednesday Friday week four-week period . The drug infuse intravenous push 10 minute dilute 10cc normal saline . Therefore , twelve intravenous infusion either GSH placebo . Randomization Randomization do computerize technique assign either GSH placebo four-week period . Clinical Assessment Assessments do baseline end one , two , three four week administration drug eight twelve week initiation trial . Patients ask come clinic approximately time day infusion . The assessment do Friday throughout trial , prior infusion glutathione/placebo one hour infusion . The following assessment do : Unified Parkinson 's Disease Rating Scale , time walk test , tap test clinical global assessment physician patient . Patient diary Parkinson 's Disease Questionnaire , quality life measurement , do weekly . Patients also videotape use standard protocol . The treat physician assessment , assessment do blind investigator . Assessment form find appendix . Safety Assessments Vital sign - orthostatic , supine stand blood pressure pulse take baseline 10 minute completion IV infusion . ECG - ECG do prior first infusion approximately 10 minute completion infusion . Adverse Reactions Adverse event report accord FDA regulation . Known side effect intravenous GSH include difficulty administer drug intravenously cause discomfort bruise site needle entry , formation small blood clot swell vein surround tissue , bleed puncture site rare occasion faint infection . Side effect glutathione include fatigue gastrointestinal disturbance . Adverse reaction assess open patient inquiry visit . Patients also instruct call PI event adverse effect throughout study . Statistical Analysis The GSH placebo group compare measure use nonparametric statistic . Mann-Whitney U comparison independent sample use detect difference two group . Significance p &lt; 0.05 .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Idiopathic Parkinson 's disease ( 2 3 cardinal symptom : tremor , bradykinesia , rigidity ) Mini Mental State Examination &gt; 24 Antiparkinsonian medication stable one month Hoehn Yahr IIIV Age 18 Atypical parkinsonism History seizure , drug addiction Use typical neuroleptic Previous use glutathione</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>Parkinson 's Disease</keyword>
	<keyword>Glutathione</keyword>
</DOC>